DYDC2抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human prostate cancer tissue using P09147(DYDC2 Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P09147(DYDC2 Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

DYDC2 (Dpy-30 domain-containing protein 2) is a conserved eukaryotic protein implicated in regulating chromatin modification and transcriptional activity. It shares structural homology with the Dpy-30 protein, a core subunit of histone methyltransferase complexes like the COMPASS family, which mediate histone H3 lysine 4 methylation (H3K4me)—a key epigenetic mark associated with active gene promoters. DYDC2 is thought to interact with chromatin-modifying enzymes, potentially influencing their targeting or enzymatic activity, though its precise molecular mechanisms remain under investigation.

Antibodies targeting DYDC2 are valuable tools for studying its expression, localization, and functional roles. These antibodies, often developed in rabbits or mice using immunogenic peptides from conserved regions of DYDC2. enable applications such as Western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP). Studies using DYDC2 antibodies have revealed its nuclear localization and involvement in cellular processes like cell differentiation, embryonic development, and transcriptional regulation. Dysregulation of DYDC2 has been linked to certain cancers and developmental disorders, underscoring its potential clinical relevance. However, antibody specificity must be rigorously validated via knockout controls due to possible cross-reactivity with homologous proteins. Current research continues to explore DYDC2's role in epigenetic regulation and disease pathways.